GoodRx HoldingsGDRX
GDRX
About: GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Employees: 694
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
253% more call options, than puts
Call options by funds: $4.22M | Put options by funds: $1.2M
35% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 34
33% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]
11% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 45
0% more funds holding
Funds holding: 165 [Q3] → 165 (+0) [Q4]
13.72% less ownership
Funds ownership: 144.1% [Q3] → 130.38% (-13.72%) [Q4]
36% less capital invested
Capital invested by funds: $986M [Q3] → $632M (-$354M) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$6
25%
upside
Avg. target
$6.08
26%
upside
High target
$6.25
30%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
Citigroup Daniel Grosslight 41% 1-year accuracy 9 / 22 met price target | 30%upside $6.25 | Buy Maintained | 10 Jan 2025 |
Keybanc Scott Schoenhaus 67% 1-year accuracy 24 / 36 met price target | 25%upside $6 | Overweight Maintained | 8 Jan 2025 |
Morgan Stanley Craig Hettenbach 33% 1-year accuracy 2 / 6 met price target | 25%upside $6 | Equal-Weight Maintained | 17 Dec 2024 |
Financial journalist opinion
Based on 3 articles about GDRX published over the past 30 days
Neutral
Business Wire
3 days ago
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web Services (AWS) has earned certified status for 2025 by HITRUST for information security. This milestone underscores GoodRx's dedication to safeguarding data and maintaining specific standards of cybersecurity in healthcare. HITRUST i1 Certification demonstrates that GoodRx's drug savings platform is leveraging a set.
Neutral
Business Wire
2 weeks ago
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025. Chris brings 30 years of extensive financial experience across the healthcare industry to his new role. Chris will join GoodRx following his role as CEO of CitizensRx, where he led the company in providing pharmacy benefit management services to commercial clien.
Neutral
Business Wire
3 weeks ago
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To acces.
Neutral
Business Wire
1 month ago
Scott Wagner Joins GoodRx Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that Scott Wagner has joined its Board of Directors, effective January 21, 2025. Mr. Wagner, who recently led GoodRx as its Interim Chief Executive Officer from April 2023 to January 2025, has been appointed as Co-Chair of the Board and will serve alongside existing Co-Chair Trevor Bezdek. Wagner joins.
Neutral
PYMNTS
1 month ago
GoodRx CFO Karsten Voermann to Resign for Personal Reasons
GoodRx Holdings disclosed Monday (Jan. 13) that its chief financial officer, Karsten Voermann, submitted his resignation Tuesday (Jan. 7), effective Friday (Jan. 16). The company attributed the resignation to “personal reasons” in a Monday filing with the Securities and Exchange Commission.
Neutral
Business Wire
1 month ago
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los Angeles County. Starting today, Angelenos can use the code LA-GOODRX-CARE to be seen by a licensed medical provider on GoodRx Care for a variety of conditions. Hundreds of thousands of Californians have been impacted by the wildfires, which may p.
Neutral
Business Wire
1 month ago
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable and convenient way for Americans to access pet medications. Through GoodRx for Pets, pet owners can find savings and have pet medications delivered right to their door. GoodRx for Pets provides a seamless experience for pet owners, combining convenience, affordability, and accessibility in one place.
Negative
CNBC
1 month ago
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Neutral
Business Wire
2 months ago
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live webcast will be available on the Company's Investor Relations website, https://investors.
Neutral
Business Wire
2 months ago
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “Endocrinologist Deserts: A Critical Healthcare Gap for Millions in the U.S.” With nearly 70% of U.S. counties lacking an endocrinologist, the report paints a stark picture of the barriers millions of Americans face in managing life-threatening conditions like diabetes. The findings come at a critical time as the.
Charts implemented using Lightweight Charts™